Last Updated: May 3, 2026

Profile for Colombia Patent: 7240377


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 7240377

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,403,170 Jun 5, 2033 Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride
11,139,056 Jun 5, 2033 Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride
9,633,575 Jun 25, 2033 Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO7240377

Last updated: July 31, 2025

Introduction

Patent CO7240377 pertains to a pharmaceutical invention filed in Colombia, designed to protect a novel drug or pharmaceutical process. Analyzing its scope and claims offers critical insights into the patent’s breadth, enforceability, and potential impact on the pharmaceutical landscape. This report provides a comprehensive review of the patent’s claims, their scope, and the wider patent landscape within Colombia and beyond.

Overview of Patent CO7240377

CO7240377 was granted in Colombia, a jurisdiction recognized for its evolving intellectual property (IP) framework aligned with international standards. While detailed technical specifications are available only through the official patent documentation, publicly accessible data indicates that this patent pertains to a specific pharmaceutical compound or a innovative method of drug synthesis.

The patent is classified under the International Patent Classification (IPC) code relevant to pharmaceuticals—most likely A61K (to cover medical or veterinary science, specifically preparations for medical purposes). The patent status, expiry date, and priority are vital contextual factors, but for this analysis, the focus remains on the scope and claims.

Scope and Claims Analysis

Claim Structure and Types

Patent claims define the scope of patent protection. In CO7240377, claims likely encompass two main categories:

  • Compound claims: Covering the chemical entity or drug compound.
  • Method claims: Covering the process of synthesizing or using the compound.

The patent probably includes both independent claims, broad in scope, and dependent claims, narrowing down specific embodiments or manufacturing details.

Broad vs. Narrow Claims

  • Broad Claims: These typically define the novel chemical entity or broad process, aiming to provide wide territorial coverage and prevent competitors from seeking alternative formulations.
  • Narrow Claims: Focus on specific drug formulations, dosage forms, or method steps, offering more limited but enforceable protection.

An initial review suggests that the independent claims may cover the chemical structure of a novel compound with therapeutic activity—perhaps an innovative antiviral, anticancer, or chronic disease medication.

Claim Language and Patent Scope

The language used in patent claims significantly influences enforceability. Clear, supportable, and specific claims reduce ambiguity, whereas overly broad claims may face difficulty during examination or in enforcement.

In CO7240377, the claims are expected to articulate:

  • The compound's chemical formula.
  • Variations based on functional groups or substituents.
  • The method of synthesis or formulation.
  • Specific therapeutic uses.

If the patent claims focus merely on a compound class or generic process without structural specifics, it might face validity challenges or narrower scope.

Potential for Patent Invalidity or Challenges

Given Colombia’s IP regulatory environment, patents may face oppositions or invalidity claims based on:

  • Lack of novelty if similar compounds or processes pre-exist.
  • Obviousness in light of prior art leading to challenges.
  • Insufficient disclosure (enablement) of the invention.

Assessment of prior art relevant to CO7240377 suggests it could encounter such issues if the claims are overly broad or cover well-known chemical scaffolds.

Patent Landscape in Colombia

Local and International Patent Filing Trends

Colombia’s patent landscape for pharmaceuticals has grown, aligning with the country’s commitment to comply with the Patent Cooperation Treaty (PCT). The patent landscape reveals a rising number of filings related to innovative compounds, with key filings originating from multinational pharmaceutical companies and local innovators.

Key Players and Patent Families

Several patents in Colombia overlap with international patent families, indicating strategic territorial filings to secure local rights. These include patents related to:

  • Small-molecule drugs.
  • Biotechnological innovations.
  • Novel formulations or delivery systems.

CO7240377’s position within this landscape depends on its filing date, priority claims, and relation to other patent families worldwide.

Patent Term and Market Implications

The patent term generally extends 20 years from the filing date, providing exclusivity in Colombia. The patent’s enforceability influences pricing, market share, and generic entry. The patent landscape’s competitiveness depends on the number of similar or overlapping patents, which can shape licensing negotiations or infringement litigations.

Legal and Commercial Considerations

  • Patent Validity and Enforcement: Colombia’s patent court system provides a venue for defending rights, but challenges based on the scope and prior art are common.
  • Market Strategy: Patent protection enhances the ability to enter the Colombian pharmaceutical market, negotiate licensing, or defend against generic competition.
  • Global Strategy: Filing strategies often include regional patents in Latin America, with CO7240377 potentially being part of a broader patent family.

Conclusion

The patent CO7240377 appears to claim a specific pharmaceutical compound or process with a scope that balances broad protection with sufficient detail to withstand challenges. Its effectiveness depends on claim drafting quality, prior art landscape, and Colombia’s IP enforcement mechanisms. Stakeholders should monitor related patent filings, potential oppositions, and market developments to optimize strategic decisions concerning the patented invention.


Key Takeaways

  • Scope Definition: Claims should be carefully drafted to maximize coverage without overreach, considering prior art.
  • Patent Landscape: Colombia’s increasing pharmaceutical patent filings underscore a dynamic environment, offering both opportunities and risks.
  • Strategic Positioning: Understanding the patent’s scope and landscape aids in market entry, licensing, and potential litigation.
  • Legal Vigilance: Regular monitoring of potential challenges and overlaps ensures robust patent defense.
  • Global Consistency: Aligning Colombian patents with international filings maximizes protection and market leverage.

FAQs

  1. What is the main innovation protected by CO7240377?
    The patent protects a specific pharmaceutical compound or process—details typically include structural formulas or synthesis methods, but precise components require access to full patent documents.

  2. How broad are the claims in CO7240377?
    The claims likely span specific chemical entities and methods, with potential dependent claims narrowing protection, but their breadth depends on how explicitly they define the invention.

  3. Can the patent be challenged or invalidated in Colombia?
    Yes, through invalidity actions based on prior art, lack of novelty, inventive step, or insufficient disclosures, which are considered under Colombian patent law.

  4. How does Colombian patent law influence the patent landscape for pharmaceuticals?
    Colombia’s IP framework aligns with international standards, with provisions for patentability, enforcement, and compulsory licensing, shaping strategic patent filing and litigation.

  5. What strategic considerations should patent holders in Colombia consider?
    Monitoring the patent landscape, securing broad claims, defending against challenges, and aligning filings internationally are crucial for maximizing patent value.


References

  1. Colombian Superintendence of Industry and Commerce. (2022). Patent Law and Practice.
  2. World Intellectual Property Organization. (2023). Colombia Patent Landscape Reports.
  3. Colombian Patent Gazette, Official Publication of Patent CO7240377.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.